首页> 外国专利> Prevention of systemic toxicity during radioimmunotherapy for intravascularly disseminated cancers

Prevention of systemic toxicity during radioimmunotherapy for intravascularly disseminated cancers

机译:在血管内弥漫性癌症的放射免疫治疗中预防全身毒性

摘要

The present invention provides a method to target delivery of antibody constructs radiolabeled with an alpha-particle emitting radionuclide to intravascularly disseminated tumor cells while minimizing systemic toxicity. Targeted delivery of a construct specific for a protein expressed on the tumor cells in combination with rapid clearance of intravascular non-targeted radiolabeled antibody construct minimizes alpha particle emissions from the radionuclide and its alpha-particle emitting decay intermediates to non-targeted cells.
机译:本发明提供了一种在最小化全身毒性的同时,将用发射有放射性核素的α粒子进行放射性标记的抗体构建体靶向递送至血管内扩散的肿瘤细胞的方法。对肿瘤细胞上表达的蛋白质特异的构建体的靶向递送与血管内非靶向放射性标记的抗体构建体的快速清除相结合,使从放射性核素及其发射α-颗粒的衰变中间体向非靶向细胞的α颗粒发射最小化。

著录项

  • 公开/公告号US2004141916A1

    专利类型

  • 公开/公告日2004-07-22

    原文格式PDF

  • 申请/专利权人 SGOUROS GEORGE;

    申请/专利号US20040753141

  • 发明设计人 GEORGE SGOUROS;

    申请日2004-01-07

  • 分类号A61K51/00;

  • 国家 US

  • 入库时间 2022-08-21 23:21:47

相似文献

  • 专利
  • 外文文献
  • 中文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号